All Stories

  1. The phospho-tau cascade, basal forebrain neurodegeneration, and dementia in Alzheimer's disease: Anti-neurodegenerative benefits of acetylcholinesterase inhibitors

    Article • Journal of Alzheimer’s Disease, November 2024, SAGE Publications

    Ruth Perez

  2. Small molecules cured mice

    Article • May 2024, IntechOpen

    Ruth Perez

  3. Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer’s Disease: Nexus of Cholinergic and Nerve Growth Factor Dysfunction

    Article • Current Alzheimer Research, November 2021, Bentham Science Publishers

    Ruth Perez

  4. FTY720-Mitoxy reduces synucleinopathy and neuroinflammation, restores behavior and mitochondria function, and increases GDNF expression in Multiple System Atrophy mouse models

    Article • Experimental Neurology, March 2020, Elsevier

    Ruth Perez

  5. Editorial introducing the Research Topic on alpha-Synuclein in Frontiers in Neuroscience

    Article • Frontiers in Neuroscience, February 2020, Frontiers

    Ruth Perez

  6. Seeking Biomarkers and Therapies for Parkinson’s Disease and Multiple System Atrophy

    Article • Journal of Parkinson’s Disease, January 2020, IOS Press

    Ruth Perez

  7. Making cells healthier with our patented compounds

    Article • Neuropharmacology, November 2019, Elsevier

    Ruth Perez

  8. Parkinsonian GM2 synthase knockout mice lacking mature gangliosides develop urinary dysfunction and neurogenic bladder

    Article • Experimental Neurology, January 2019, Elsevier

    Ruth Perez

  9. Up-regulation of protective neuronal MicroRNAs by FTY720 and novel FTY720-derivatives

    Article • Neuroscience Letters, January 2019, Elsevier

    Ruth Perez

  10. Could α-Synuclein Modulation of Insulin and Dopamine Identify a Novel Link Between Parkinson’s Disease and Diabetes as Well as Potential Therapies?

    Article • Frontiers in Molecular Neuroscience, December 2018, Frontiers

    Ruth Perez

  11. Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays

    Article • Journal of Visualized Experiments, August 2017, MyJove Corporation

    Ruth Perez

  12. FTY720 (Fingolimod) reverses α-synuclein-induced downregulation of brain-derived neurotrophic factor mRNA in OLN-93 oligodendroglial cells

    Article • Neuropharmacology, May 2017, Elsevier

    Ruth Perez

  13. Safer compounds for Parkinson's disease and related disorders

    Article • Journal of Pharmacological Sciences, March 2017, Elsevier

    Ruth Perez

  14. FTY720/Fingolimod Reduces Synucleinopathy and Improves Gut Motility in A53T Mice

    Article • Journal of Biological Chemistry, August 2016, American Society for Biochemistry & Molecular Biology (ASBMB)

    Ruth Perez